ID

29220

Beschreibung

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00614120

Link

https://clinicaltrials.gov/show/NCT00614120

Stichworte

Versionen (1)
  1. 08.03.18 08.03.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

8. März 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT00614120

Englisch

Eligibility Diabetes NCT00614120

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00614120
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
subjects diagnosed with type 2 diabetes and treated with one or more oral antidiabetic drugs (oads) for the last 3 months
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent | Antidiabetics Oral Quantity

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C1265611
hba1c: 7.0-11.0% (both incl.) for subjects on oad alone
Beschreibung

Glucohemoglobin measurement | Antidiabetics Oral Alone

Datentyp

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0205171
hba1c: 7.0-10.0 % (both incl.) for subjects on oad combination therapy
Beschreibung

Glucohemoglobin measurement | Antidiabetics Oral | Combined Modality Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [3]
C0009429
bmi less than 45.0 kg/m^2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with insulin within the last 3 months prior to the trial
Beschreibung

Insulin regime

Datentyp

boolean

Alias
UMLS CUI [1]
C0557978
impaired liver or/and renal function
Beschreibung

Liver Dysfunction | Renal Insufficiency

Datentyp

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1565489
significant cardiovascular disease over the last 6 months
Beschreibung

Cardiovascular Disease Disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0872146
known retinopathy or maculopathy
Beschreibung

Retinal Disease | Disorder of macula of retina

Datentyp

boolean

Alias
UMLS CUI [1]
C0035309
UMLS CUI [2]
C0730362
recurrent major hypoglycaemia or hypoglycaemic unawareness
Beschreibung

Recurrent severe hypoglycemia | Loss of hypoglycemic warning

Datentyp

boolean

Alias
UMLS CUI [1]
C0342316
UMLS CUI [2]
C0342317
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diabetes NCT00614120

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00614120
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Antidiabetics Oral Quantity
Item
subjects diagnosed with type 2 diabetes and treated with one or more oral antidiabetic drugs (oads) for the last 3 months
boolean
C0011860 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Glucohemoglobin measurement | Antidiabetics Oral Alone
Item
hba1c: 7.0-11.0% (both incl.) for subjects on oad alone
boolean
C0202054 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0205171 (UMLS CUI [2,3])
Glucohemoglobin measurement | Antidiabetics Oral | Combined Modality Therapy
Item
hba1c: 7.0-10.0 % (both incl.) for subjects on oad combination therapy
boolean
C0202054 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0009429 (UMLS CUI [3])
Body mass index
Item
bmi less than 45.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Insulin regime
Item
treatment with insulin within the last 3 months prior to the trial
boolean
C0557978 (UMLS CUI [1])
Liver Dysfunction | Renal Insufficiency
Item
impaired liver or/and renal function
boolean
C0086565 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Cardiovascular Disease Disease length
Item
significant cardiovascular disease over the last 6 months
boolean
C0007222 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Retinal Disease | Disorder of macula of retina
Item
known retinopathy or maculopathy
boolean
C0035309 (UMLS CUI [1])
C0730362 (UMLS CUI [2])
Recurrent severe hypoglycemia | Loss of hypoglycemic warning
Item
recurrent major hypoglycaemia or hypoglycaemic unawareness
boolean
C0342316 (UMLS CUI [1])
C0342317 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video